We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Internet Diabetes Self-Management Workshop

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00185601
First Posted: September 16, 2005
Last Update Posted: April 19, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by (Responsible Party):
Kate Lorig, Stanford University
  Purpose

The purpose of this study is to determine of the effectiveness of an Internet based Diabetes Self-Management workshop for people with type II diabetes. Half of the people who complete the workshop will be invited to continue their education by participating in a email discussion group. Thus, we will be able to learn both the efficacy of the original program as well as its efficacy when reinforced by the discussion group.

Diabetes is a disease that must be managed day by day by the individual with the disease. Although we know a great deal about the self-management of type II diabetes, most self-management is less than optimal. In addition, most people with diabetes do not have an opportunity to participate in formal diabetes education. This study will determine if an Internet delivered educational workshop will help people with diabetes manage their disease. Thus we will be measuring changes in behaviors, changes in symptoms and changes in HbA1c, blood pressure, cholesterol, and weight. If successful the workshop will serve as a prototype for Internet diabetes education.


Condition Intervention
Diabetes Mellitus, Type 2 Behavioral: Internet Diabetes Self-Management Program

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Internet Diabetes Self-Management Evaluation

Further study details as provided by Kate Lorig, Stanford University:

Primary Outcome Measures:
  • HbA1c [ Time Frame: 6 and 12 months ]

Secondary Outcome Measures:
  • Outcome Measure: Health-related quality of life [ Time Frame: 6 and 12 months ]
  • Outcome Measure: Health behaviors [ Time Frame: 6 and 12 months ]
  • Health care utilization [ Time Frame: 6 and 12 months ]

Enrollment: 761
Study Start Date: February 2006
Study Completion Date: June 2010
Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
on-line self management intervention Behavioral: Internet Diabetes Self-Management Program
No Intervention: usual care control group
Experimental: on-line self management intervention with email reinforcement Behavioral: Internet Diabetes Self-Management Program

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria::- Diabetes type 2

  • Have internet access and email address
  • Live in the United States
  • 18 years of age or older

Exclusion Criteria:- Previous participation in similar online or community-based self-management program

  • Active treatment for cancer
  • Pregnant
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00185601


Locations
United States, California
Stanford University School of Medicine
Stanford, California, United States, 94305
Sponsors and Collaborators
Stanford University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Investigators
Principal Investigator: Kate R Lorig Stanford University
  More Information

Additional Information:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Kate Lorig, professor emertius, Stanford University
ClinicalTrials.gov Identifier: NCT00185601     History of Changes
Other Study ID Numbers: 5R18DK065729-02 ( U.S. NIH Grant/Contract )
First Submitted: September 9, 2005
First Posted: September 16, 2005
Last Update Posted: April 19, 2013
Last Verified: April 2013

Additional relevant MeSH terms:
Diabetes Mellitus
Diabetes Mellitus, Type 2
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases